FDA chief Martin Makary sets June deadline for genAI rollout
The US Food and Drug Administration (FDA) has set an "aggressive" timeline to implement generative artificial intelligence (genAI) across the…
News
Haya secures $65m in Series A funds to advance heart failure treatment
Sanofi exec tells biotechs not to scrimp on clinical trial design
Viralgen and Trogenix to progress gene therapy for glioblastoma
VC firm Vivo Capital outlays $740m for biotech investment
BioVaxys and Sona partner to develop cancer therapeutics
ARS Pharma’s epinephrine nasal spray 1mg now available in US
FDA plans to expand unannounced inspections of foreign drug plants
